Griffin Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.46M | Buy |
143,861
+20,713
| +17% | +$542K | 0.37% | 69 |
|
|
2026
Q1 | $3.46M | Sell |
123,148
-16,018
| -12% | -$426K | 0.39% | 71 |
|
|
2025
Q4 | $3.47M | Sell |
139,166
-3,918
| -3% | -$98.8K | 0.37% | 67 |
|
|
2025
Q3 | $3.65M | Buy |
143,084
+14,284
| +11% | +$353K | 0.41% | 69 |
|
|
2025
Q2 | $3.12M | Buy |
128,800
+20,134
| +19% | +$470K | 0.37% | 74 |
|
|
2025
Q1 | $2.75M | Buy |
108,666
+26,548
| +32% | +$695K | 0.34% | 83 |
|
|
2024
Q4 | $2.18M | Sell |
82,118
-12,489
| -13% | -$339K | 0.26% | 91 |
|
|
2024
Q3 | $2.74M | Buy |
94,607
+8,138
| +9% | +$237K | 0.31% | 80 |
|
|
2024
Q2 | $2.42M | Buy |
86,469
+18,480
| +27% | +$509K | 0.28% | 82 |
|
|
2024
Q1 | $1.89M | Buy |
67,989
+7,943
| +13% | +$220K | 0.23% | 94 |
|
|
2023
Q4 | $1.73M | Buy |
60,046
+6,940
| +13% | +$210K | 0.22% | 97 |
|
|
2023
Q3 | $1.76M | Buy |
53,106
+80
| +0.2% | +$2.83K | 0.25% | 89 |
|
|
2023
Q2 | $1.95M | Sell |
53,026
-21,338
| -29% | -$831K | 0.26% | 93 |
|
|
2023
Q1 | $3.03M | Sell |
74,364
-582
| -0.8% | -$25.1K | 0.42% | 63 |
|
|
2022
Q4 | $3.84M | Buy |
74,946
+2,346
| +3% | +$112K | 0.58% | 55 |
|
|
2022
Q3 | $3.18M | Buy |
72,600
+273
| +0.4% | +$13.3K | 0.53% | 56 |
|
|
2022
Q2 | $3.79M | Buy |
72,327
+1,049
| +1% | +$53.5K | 0.61% | 48 |
|
|
2022
Q1 | $3.69M | Buy |
71,278
+9,041
| +15% | +$469K | 0.48% | 60 |
|
|
2021
Q4 | $3.67M | Buy |
62,237
+7,967
| +15% | +$395K | 0.46% | 59 |
|
|
2021
Q3 | $2.33M | Buy |
54,270
+5,251
| +11% | +$233K | 0.3% | 85 |
|
|
2021
Q2 | $1.92M | Sell |
49,019
-2,667
| -5% | -$104K | 0.23% | 103 |
|
|
2021
Q1 | $1.87M | Sell |
51,686
-2,713
| -5% | -$96.3K | 0.24% | 95 |
|
|
2020
Q4 | $2M | Sell |
54,399
-4,661
| -8% | -$171K | 0.27% | 85 |
|
|
2020
Q3 | $2.06M | Buy |
59,060
+2,924
| +5% | +$103K | 0.32% | 71 |
|
|
2020
Q2 | $1.74M | Sell |
56,136
-975
| -2% | -$33.1K | 0.28% | 77 |
|
|
2020
Q1 | $1.77M | Sell |
57,111
-12,071
| -17% | -$411K | 0.34% | 69 |
|
|
2019
Q4 | $2.57M | Buy |
69,182
+627
| +0.9% | +$22.3K | 0.36% | 72 |
|
|
2019
Q3 | $2.34M | Sell |
68,555
-29,347
| -30% | -$1.07M | 0.36% | 70 |
|
|
2019
Q2 | $4.02M | Buy |
97,902
+340
| +0.3% | +$13.5K | 0.51% | 57 |
|
|
2019
Q1 | $3.93M | Sell |
97,562
-1,308
| -1% | -$52.4K | 0.56% | 56 |
|
|
2018
Q4 | $4.09M | Buy |
98,870
+200
| +0.2% | +$8.3K | 0.69% | 49 |
|
|
2018
Q3 | $4.13M | Buy |
98,670
+5,896
| +6% | +$227K | 0.61% | 52 |
|
|
2018
Q2 | $3.19M | Sell |
92,774
-6,192
| -6% | -$212K | 0.58% | 58 |
|
|
2018
Q1 | $3.33M | Buy |
98,966
+6,635
| +7% | +$228K | 0.61% | 54 |
|
|
2017
Q4 | $3.17M | Buy |
92,331
+32,895
| +55% | +$1.12M | 0.56% | 57 |
|
|
2017
Q3 | $2.01M | Buy |
59,436
+35,334
| +147% | +$1.14M | 0.36% | 78 |
|
|
2017
Q2 | $768K | Buy |
+24,102
| New | +$760K | 0.21% | 85 |
|
|
2015
Q4 | $449K | Sell |
14,676
-9,179
| -38% | -$289K | 0.19% | 69 |
|
|
2015
Q3 | $711K | Buy |
23,855
+5,121
| +27% | +$164K | 0.3% | 59 |
|
|
2015
Q2 | $596K | Sell |
18,734
-23,574
| -56% | -$768K | 0.23% | 64 |
|
|
2015
Q1 | $1.4M | Sell |
42,308
-579
| -1% | -$18.4K | 0.41% | 60 |
|
|
2014
Q4 | $1.27M | Buy |
42,887
+16,012
| +60% | +$459K | 0.34% | 64 |
|
|
2014
Q3 | $754K | Buy |
26,875
+14,956
| +125% | +$420K | 0.23% | 70 |
|
|
2014
Q2 | $336K | Buy |
11,919
+1,305
| +12% | +$37.2K | 0.11% | 89 |
|
|
2014
Q1 | $323K | Sell |
10,614
-4,458
| -30% | -$133K | 0.1% | 90 |
|
|
2013
Q4 | $438K | Hold |
15,072
| – | – | 0.14% | 81 |
|
|
2013
Q3 | $411K | Hold |
15,072
| – | – | 0.13% | 84 |
|
|
2013
Q2 | $401K | Buy |
+15,072
| New | +$416K | 0.15% | 82 |
|
Other funds holding PFE
Griffin Asset Management's PFE Position: Q2 2026 in Review
Griffin Asset Management increased its Pfizer (PFE) stake by 17% in Q2 2026, buying an estimated $542K and bringing the position to 143,861 shares worth $3.46M. The position accounts for 0.37% of the portfolio, ranked #69.
Griffin Asset Management first reported a position in PFE in Q2 2013 and has held it in 48 quarters since. The position peaked at $4.13M in Q3 2018. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Griffin Asset Management held 143,861 shares of Pfizer worth $3.46M as of Q2 2026.
- Griffin Asset Management bought 20,713 Pfizer shares in Q2 2026, an estimated $542K.
- Pfizer made up 0.37% of Griffin Asset Management's portfolio in Q2 2026, its #69 holding.
- Griffin Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 48 quarters since.
- Griffin Asset Management's Pfizer position peaked at $4.13M in Q3 2018.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Griffin Asset Management's 13F filing for Q2 2026, filed 23 Jul 2026.